Ambri revenue, loss down
Thursday, 25 August, 2005
Ambri (ASX:ABI) saw a decrease in its revenue for the 2004-05 financial year of 27 per cent to $1 million (from $1.4 million in the previous year) but the company's loss was also down 22 per cent to $9 million.
Total expenses for 2004-05 were $10 million compared with $12.8 million in 2003-04, due to a reduction in headcount and R&D spending. The company halved its workforce from 76 to 32 people over the financial year, reducing employee expenses to $4.6 million.
Ambri had cash assets of $10.9 million at June 30, 2005.
Personalised melanoma vaccine cuts risk of recurrence
Adding a personalised, mRNA-based cancer vaccine to standard immunotherapy after surgery for...
Research project to produce fish-free omega-3
SCU researchers are investigating how to grow omega-3-producing microorganisms more cheaply...
Biodegradable smart patch can detect and treat blood clots
Researchers have developed a biodegradable smart patch that detects pressure changes and releases...
